Charting new
territory in Molecular
Glue Discovery
Leadership
Board of Directors
Scientific Advisory Board
Markus Warmuth
Chief Executive Officer
Ajim Tamboli
Chief Financial Officer
Owen Wallace
Chief Scientific Officer
Sharon Townson
Chief Technology Officer
John Castle
Chief Data Scientist
Filip Janku
Chief Medical Officer
Jullian Jones
Chief Business Officer
Phil Nickson
General Counsel
Magnus Walter
SVP, Chemical Sciences and Process Development
Jennifer Champoux
Chief People and Operations Officer
Alexander Mayweg (Chair)
President, Ridgeline Discovery & Managing Director, Versant Ventures
Ali Behbahani
General Partner, New Enterprise Associates
Kimberly Blackwell
Chief Executive Officer, Zentalis Pharmaceuticals
Chandra P. Leo
Investment Advisor, HBM Partners
Andrew Schiff
Managing Partner, Aisling Capital
Christine Siu
Chief Operating Officer in Residence, BridgeBio
Markus Warmuth
Chief Executive Officer, Monte Rosa Therapeutics & Venture Partner, Versant Ventures
Jan Skvarka
Executive Chairman, DEM Biopharma
Nicolas Thomä
Group Leader, Friedrich Miescher Institute for Biomedical Research
Eliezer Van Allen
Associate Professor, Dana-Farber Cancer Institute and Harvard Medical School; Associate Member, Broad Institute of MIT and Harvard
Michael Rape
Professor of Cell and Developmental Biology, University of California, Berkeley; Investigator, Howard Hughes Medical Institute
Kimberly Blackwell
Chief Executive Officer, Zentalis Pharmaceuticals
David Schenkein
General Partner, GV
Nir London
Senior Scientist (Assistant Professor), Weizmann Institute of Science
Are you ready to take
your career to new heights?
Are you ready to take
your career to new heights?
We are looking for enthusiastic and energetic candidates ready for their next adventure. Sound like you? Clip in, and help us scale new heights.